NICE recommends mirikizumab as a treatment option for Crohn’s disease Mirikizumab (Omvoh; Eli Lilly), which is already licensed to treat ulcerative colitis but at a lower dose, is now recommended for the treatment of moderately to severely active Crohn's disease.…
Walk-in flu vaccine finder for community pharmacy to be launched for 2025/2026 flu season NHS England said the “flu walk-in finder” was developed in response to patient feedback that complained of restrictions to the national booking service and a lack of information on clinic times.…
Urgent reform needed to fulfil Pharmacy First potential, say pharmacy and GP leaders Exclusive: A joint letter from local pharmaceutical committees and local medical committees in London has called on the government to improve patient access to Pharmacy First.…
Pharmacy First passes 5 million consultations landmark Data also show that in the first 13 months of the service, acute sore throat was the most common condition that patients sought help for, with more than 800,000 Pharmacy First consultations.…
NHS pharmacogenomics trial expands to 20 sites across England The PROGRESS trial is planned to finish in early 2026, with an impact assessment produced in the fourth quarter of 2025/2026.…
Prescription tracking app to be used by more than 5,000 pharmacies within a year, says NHS England NHS England said the tracking feature will reduce how long pharmacists spend on the phone and give them more time to offer advice to patients.…
Hospital pharmacists awarded 3.6% pay rise The Guild of Healthcare Pharmacists said the pay award does not go far enough in reversing the below-inflation awards seen in previous years.…
NHS England looks to tender contract for behavioural support for patients prescribed tirzepatide in primary care The NHS England document said that patients prescribed tirzepatide in primary care settings will receive “high-quality behavioural wrap-around care” as well as clinical support.…
Funding gap: economic analysis paints dire picture of community pharmacy’s sustainability An independent economic analysis has revealed that the cost of delivering community pharmacy NHS services in England far outstrips the funding available, even after the uplift agreed in the latest contract negotiations.…
Decline in pharmacy access in most deprived areas four times greater than in least deprived, study results show Authors found that, between 2014 and 2023, there was an almost 12% decrease in the number of community pharmacies in the most deprived areas of England compared with a 3% reduction in the least deprived areas.…
